person

Charles Eric L.

Country
France
Department
Urgences

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 6 partner sites.

Specializations

Head and Neck Oncology

The investigator focuses on malignant neoplasms of the oral cavity, oropharynx, hypopharynx, and larynx, including both resected and unresected disease.

  • Radiotherapy combined with targeted agents
  • Neoadjuvant chemotherapy strategies
  • Immunotherapy integration for squamous cell carcinoma

Active involvement in trials evaluating organ preservation and disease‑free survival.

Critical Care and Respiratory Medicine

Specialized in severe pulmonary conditions such as chronic pulmonary aspergillosis and acute hypoxemic failure requiring intensive support.

  • Adjunctive antifungal regimens
  • Corticosteroid and mineralocorticoid therapy for CIRCI
  • High‑flow nasal oxygen strategies during intubation

Research aims to reduce ventilator dependence and improve mortality in critically ill patients.

Gastrointestinal and Hepatic Oncology

Investigates malignant tumors of the pancreas, colorectal tract, and hepatocellular carcinoma, emphasizing targeted and combination therapies.

  • CLDN18.2‑positive pancreatic adenocarcinoma treatments
  • Metronomic chemotherapy with anti‑angiogenic agents
  • Regorafenib‑based regimens for refractory colorectal cancer

Efforts target progression‑free and overall survival improvements.

Hematologic and Bone Marrow Disorders

Engaged in studies of myelodysplastic syndromes and related anemia, including molecularly defined subgroups.

  • Erythropoiesis‑stimulating agent timing
  • IDH1‑mutated MDS therapeutic assessment
  • Transfusion‑independence endpoints

Focuses on disease modification and quality‑of‑life outcomes.

Autoimmune and Infectious Disease Modulation

Addresses immune dysregulation in conditions such as rheumatoid arthritis and severe community‑acquired infections.

  • Combination anti‑TNF and JAK inhibition
  • Interferon‑γ prophylaxis for secondary infections
  • Broad‑spectrum immunoglobulin adjuncts in pneumonia

Research seeks to balance immunosuppression with infection control.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.